Your assessment suggests your organization has taken some steps toward HIPAA-conscious marketing. These are the areas worth keeping an eye on.
| Area | Signal | Status |
|---|---|---|
Tracking tools Analytics and ad platform tracking in use | Standard tracking tools present. Risk depends on how they’re configured and whether a compliant CDP is filtering events before they reach ad platforms. | Worth reviewing |
BAA coverage Business Associate Agreements with vendors | Your responses suggest BAA coverage may be in place or partially addressed. Confirm all marketing and analytics vendors are covered. | Lower risk |
Conversion events Data sent back to ad platforms | Conversion data flows may be present. If a HIPAA-compliant CDP with a signed BAA is in place before events reach Google or Meta, your exposure is managed. | Lower risk |
Prevention steps Protections against PHI reaching ad platforms | Some protections appear to be in place. A periodic review ensures they remain effective as your tracking setup evolves. | Lower risk |
This is a high-level sweep based on your answers. A full review with Grayvault and OursPrivacy takes 30 minutes and surfaces specifics your setup may not reveal on its own.
Book a free compliance reviewImportant note: This assessment is a high-level sweep based on your self-reported answers. It is not a legal compliance determination and does not constitute legal advice. A human-reviewed assessment using a full compliance tool is required to accurately identify and address your specific HIPAA exposure. Results reflect general risk patterns, not a verified audit of your actual marketing infrastructure.